SABBY MANAGEMENT, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$301,000
-50.2%
98,602
-30.9%
0.01%
-45.5%
Q2 2015$605,000
-24.9%
142,700
-31.7%
0.02%
-35.3%
Q1 2015$806,000
-23.6%
208,928
+103.0%
0.03%
-24.4%
Q2 2014$1,055,000
+89.7%
102,900
+122.2%
0.04%
+45.2%
Q1 2014$556,000
-38.4%
46,316
-42.0%
0.03%
-46.6%
Q4 2013$903,000
-43.4%
79,833
-46.1%
0.06%
-44.2%
Q3 2013$1,595,000148,0700.10%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders